J A Norton - Concepedia

Author

J A Norton

National Institutes of Health

Also Known As

J A Norton, J Norton, Judy Norton

Publications

889

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health Washington University in St. Louis National Cancer Institute

About

J A Norton is an author at National Institutes of Health specializing in medicine, pathology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	422
2	Gastroenterology	3	3	220
3	Endocrinology	1	1	39
4	Hepatology	1	1	132
5	Immunology	1	1	75

J A Norton

Publications

884

Citations

H-Index

Page 1

	Year	Citations
Pentoxifylline suppression of tumor necrosis factor gene transcription. Gerard M. Doherty, J C Jensen, H. Richard Alexander, PubMed	1991	308
Gastrinomas: localization by means of selective intraarterial injection of secretin. John L. Doppman, Debra L. Miller, Richard Chang, Radiology HepatologySelective Intraarterial InjectionPancreatic Fluid CollectionSelective AngiographyHistopathology	1990	132
Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1. A. Bale, J A Norton, Emily L. Wong, PubMed Cancer PathologyGeneticsGenetic EpidemiologyPathologySporadic Tumors	1991	114
High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12. Jennifer B. Meko, Jeongbin Yim, Kangla Tsung, PubMed Effective Antitumor ActivityMurine Interleukin 12ImmunologyImmunoeditingPathology	1995	75
Inhibition of established rat fibrosarcoma growth by the glucose antagonist 2-deoxy-D-glucose. Kara Kern, J A Norton PubMed	1987	61
Zollinger-Ellison syndrome: technique, results, and complications of portal venous sampling. Debra L. Miller, John L. Doppman, David C. Metz, Radiology Gastrinoma TriangleSurgical OncologyPancreatic Fluid CollectionPortal HypertensionInterventional Endoscopic Ultrasound	1992	49
IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice J.H. Yim, Susan Wu, Mícheál Casey, The Journal of Immunology	1997	40
Endocrine tumors of the pancreas. Jennifer B. Meko, J A Norton PubMed Surgical OncologyGastroenterologyPathologySurgeryEndoscopic Imaging	1994	39
The Treatment of Malignant Mesothelioma with a Gene Modified Cancer Cell Line: A Phase I Study. Louisiana State University Medical Center, New Orleans Paul Schwarzenberger, Lynn Harrison, Ann Weinacker, Human Gene Therapy	1998	33
The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors. Howard N. Langstein, J A Norton, Vincent L. Chiang, PubMed	1990	20

Page 1